These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21670176)

  • 21. In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus.
    Swenson JM; Tenover FC
    J Antimicrob Chemother; 2002 May; 49(5):845-50. PubMed ID: 12003982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.
    Tewhey R; Gu B; Kelesidis T; Charlton C; Bobenchik A; Hindler J; Schork NJ; Humphries RM
    mBio; 2014 May; 5(3):e00894-14. PubMed ID: 24915435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods.
    Tubau F; Fernández-Roblas R; Liñares J; Martín R; Soriano F
    J Antimicrob Chemother; 2001 May; 47(5):675-80. PubMed ID: 11328783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).
    Bolmstrom A; Ballow CH; Qwarnstrom A; Biedenbach DJ; Jones RN
    Clin Microbiol Infect; 2002 Dec; 8(12):791-800. PubMed ID: 12519352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
    Ross JE; Fritsche TR; Sader HS; Jones RN
    Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-infection by two linezolid-resistant coagulase-negative staphylococci with two different resistance determinants.
    Mazzariol A; Kocsis E; Bragagnolo L; Pellizzer G; Rassu M; Cornaglia G
    Scand J Infect Dis; 2012 Dec; 44(12):978-81. PubMed ID: 22830638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-Year Summary of
    Pfaller MA; Mendes RE; Streit JM; Hogan PA; Flamm RK
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyphyletic emergence of linezolid-resistant staphylococci in the United States.
    Wong A; Reddy SP; Smyth DS; Aguero-Rosenfeld ME; Sakoulas G; Robinson DA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):742-8. PubMed ID: 19933808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific.
    Bell JM; Turnidge JD; Ballow CH; Jones RN;
    J Antimicrob Chemother; 2003 Feb; 51(2):339-45. PubMed ID: 12562700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.
    Mendes RE; Deshpande LM; Costello AJ; Farrell DJ
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4656-61. PubMed ID: 22687512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid-resistant clinical isolates of meticillin-resistant coagulase-negative staphylococci and Enterococcus faecium from China.
    Cai JC; Hu YY; Zhang R; Zhou HW; Chen GX
    J Med Microbiol; 2012 Nov; 61(Pt 11):1568-1573. PubMed ID: 22899781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of linezolid resistance among Staphylococci in a tertiary hospital.
    Quiles-Melero I; Gómez-Gil R; Romero-Gómez MP; Sánchez-Díaz AM; de Pablos M; García-Rodriguez J; Gutiérrez A; Mingorance J
    J Clin Microbiol; 2013 Mar; 51(3):998-1001. PubMed ID: 23269737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
    Meka VG; Gold HS; Cooke A; Venkataraman L; Eliopoulos GM; Moellering RC; Jenkins SG
    J Antimicrob Chemother; 2004 Oct; 54(4):818-20. PubMed ID: 15347637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
    Ross JE; Anderegg TR; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 May; 52(1):53-8. PubMed ID: 15878443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
    Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12).
    Mendes RE; Hogan PA; Streit JM; Jones RN; Flamm RK
    J Antimicrob Chemother; 2014 Jun; 69(6):1582-8. PubMed ID: 24468866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):199-209. PubMed ID: 17908617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.
    Ho PL; Ng TK; Yung RW; Que TL; Yip EK; Tse CW; Yuen KY
    J Antimicrob Chemother; 2001 Oct; 48(4):590-2. PubMed ID: 11581246
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of linezolid- and methicillin-resistant coagulase-negative staphylococci in a tertiary hospital in China.
    Liu C; Yu J; Chen C; Li X; Ye Y; Dong Y; Ying X; Li H; Wang W
    BMC Infect Dis; 2024 May; 24(1):486. PubMed ID: 38730362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.